The external hardware typically sits on top of the ear or around the head and prohibits all manner of vigorous ...

Novo Nordisk’s massively successful GLP-1 analog semaglutide, the active ingredient in the popular diabetes and obesity meds ...

Being prescribed semaglutide for diabetes or weight management is associated with an increased risk, up to seven times, of ...

Researchers say they have uncovered a link between semaglutide — the active ingredient in Ozempic and Wegovy — and sudden ...

Patients who took the drugs for weight loss were more than seven times more likely to be diagnosed with a stroke-like eye ...

BOSTON - Researchers in Massachusetts are one step closer to finding a cure for tinnitus. Up to 10% of adults worldwide ...

Prescriptions with semaglutide (Wegovy, Ozempic, Novo Nordisk) are FDA approved to treat obesity and type 2 diabetes, ...

Massachusetts Eye and Ear (Mass. Eye and Ear, or MEE) is a specialty hospital located in Boston, Massachusetts, United States, which focuses on ophthalmology (eye), otolaryngology (ear/nose/throat ...

A team of researchers, led by those from the Massachusetts Eye and Ear hospital, US, found that patients with obesity who ...

A new observational study reported for the first time a potential link between Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy ...

Semaglutide, the active ingredient in brand medicines like Ozempic and Wegovy, could raise the risk of a relatively rare eye ...

I have heard a similar story throughout my adult life. People say that they have trouble hearing and understanding ...